| scholarly article | Q13442814 |
| P2093 | author name string | Justin Kosak | |
| Thomas E Eling | |||
| Xingya Wang | |||
| Kali Chrysovergis | |||
| P2860 | cites work | Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 |
| MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity | Q29614283 | ||
| Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling | Q29616024 | ||
| The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance | Q29616026 | ||
| Type 2 diabetes as an inflammatory disease | Q29617184 | ||
| Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes | Q33918445 | ||
| Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes | Q34149544 | ||
| Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. | Q34426322 | ||
| Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance. | Q34723169 | ||
| Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. | Q35043422 | ||
| Inflammasome is a central player in the induction of obesity and insulin resistance | Q35216914 | ||
| The H6D variant of NAG-1/GDF15 inhibits prostate xenograft growth in vivo | Q35531969 | ||
| The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer | Q36592451 | ||
| Mechanisms of disease: inflammasome activation and the development of type 2 diabetes | Q36668052 | ||
| NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response | Q36869509 | ||
| The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity | Q36931760 | ||
| Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice | Q37110553 | ||
| The NLRP3 inflammasome: a sensor for metabolic danger? | Q37675505 | ||
| Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family | Q38034273 | ||
| Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. | Q40056643 | ||
| Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion | Q41585297 | ||
| Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression | Q41862754 | ||
| Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes | Q42805165 | ||
| Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. | Q43414241 | ||
| Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. | Q45974276 | ||
| Differential expression of NLRP3 among hematopoietic cells. | Q50528108 | ||
| Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity. | Q51372416 | ||
| Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. | Q51496934 | ||
| The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients | Q58788278 | ||
| Adipose tissue as an endocrine organ | Q79189502 | ||
| Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia | Q79353945 | ||
| Linking the inflammasome to obesity-related disease | Q83379079 | ||
| Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance | Q83864443 | ||
| The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue | Q84813098 | ||
| P433 | issue | 5 | |
| P921 | main subject | obesity | Q12174 |
| inflammasome complex | Q412405 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1256-1263 | |
| P577 | publication date | 2013-12-05 | |
| P1433 | published in | Obesity | Q15763232 |
| P1476 | title | Lower NLRP3 inflammasome activity in NAG-1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity | |
| P478 | volume | 22 |
| Q38380755 | Acute rhabdomyolysis and inflammation |
| Q89967548 | Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease |
| Q92385169 | Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults |
| Q28552243 | Expression of Human NSAID Activated Gene 1 in Mice Leads to Altered Mammary Gland Differentiation and Impaired Lactation |
| Q35126861 | Letter: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9) |
| Q45057004 | NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury |
| Q45323971 | Over-production of growth differentiation factor 15 (GDF15) promotes human rhinovirus infection and virus-induced inflammation in the lung. |
| Q37062591 | Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes |
| Q53693528 | Reduced oxidative capacity in macrophages results in systemic insulin resistance. |
| Q35909717 | Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway |
| Q48574810 | Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity |
| Q34217628 | hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling |
Search more.